Maxeler Technologies (London, UK), a leader in optimization of computational data movement, is collaborating with Professor Ophir Frieder at Georgetown University (Washington DC, USA) to commercialize Georgetown AI research aimed at reducing patient adverse effects related to errors in drug prescriptions, on Maxeler’s M-Space Software Delivery Platform. The novel AI prescription prediction techno